Needham & Company LLC reissued their hold rating on shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. Other equities analysts have also recently issued reports about the company. JPMorgan Chase & Co. started coverage on Amphastar Pharmaceuticals in a research note on Tuesday, […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) Director Floyd F. Petersen sold 500 shares of the stock in a transaction on Monday, April 1st. The stock was sold at an average price of $43.43, for a total value of $21,715.00. Following the completion of the sale, the director now directly owns 79,333 shares in […]
Amphastar Pharmaceuticals, Inc (NASDAQ:AMPH) Director Sells $21,715 00 in Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Legato Capital Management LLC grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 95.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,217 shares of the company’s stock after purchasing an additional 7,431 shares during the period. Legato […]
Nordea Investment Management AB trimmed its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.1% during the third quarter, Holdings Channel.com reports. The fund owned 338,443 shares of the company’s stock after selling 349 shares during the quarter. Nordea Investment Management AB’s holdings in Amphastar Pharmaceuticals were worth $15,700,000 as of […]